ArticleApplied biochemistry and biotechnology2026
Internal Heat Acupuncture Treatment Inhibits Ferroptosis in the Spinal Dorsal Horn in Neurotoxin-Induced Parkinson's Disease Rats.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Parkinson’s disease (PD) is the second neurodegenerative disorder with limited therapeutic options. Ferroptosis is involved in the pathogenesis of PD. This study aimed to investigate the neuroprotective effects of internal heat acupuncture (IHA) in a PD model, focusing on its impact on ferroptosis. A neurotoxin-induced PD rat model was established using 6-hydroxydopamine (6-OHDA). These rats received IHA therapy. Behavioral tests were conducted to assess motor function and neuropathic pain. Serum inflammatory cytokines were evaluated by enzyme-linked immunosorbent assay. Ferroptosis markers and the role of the GSK3β/Nrf2/GPX4 pathway were measured by western blot. The results showed that IHA enhanced motor function, attenuated pain hypersensitivity, and suppressed systemic inflammation in PD rats. Concurrently, IHA inhibited ferroptosis in the spinal dorsal horn of PD rats, evidenced by decreased lipid peroxidation and iron accumulation, restored antioxidant capacity, and downregulated ferroptosis- and ferritinophagy-related markers. In addition, IHA decreased GSK3β expression and upregulated the Nrf2 and GPX4 expression, and overexpression of GSK3β reversed the effect on PD rats induced by IHA. In conclusion, IHA treatment suppresses ferroptosis in the spinal dorsal horn by targeting the GSK3β/Nrf2/GPX4 pathway, thereby alleviating PD-induced motion disorders, neuropathic pain, and inflammation. These findings suggest that IHA may be an effective approach to treating PD and reveal a mechanism of its action.
Indexed as
Identifiers
41854854What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.